TWO SIGMA INVESTMENTS, LP - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 275 filers reported holding FATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.7%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,500,697
-61.6%
1,651,272
-13.9%
0.01%
-60.9%
Q2 2023$9,127,514
-11.2%
1,917,545
+6.3%
0.02%
-20.7%
Q1 2023$10,277,573
-32.3%
1,803,083
+19.9%
0.03%
-39.6%
Q4 2022$15,172,838
+258.1%
1,503,750
+695.4%
0.05%
+242.9%
Q3 2022$4,237,000
+392.7%
189,067
+1186.2%
0.01%
+600.0%
Q4 2021$860,000
-95.2%
14,700
-95.1%
0.00%
-95.0%
Q3 2021$17,754,000
-30.2%
299,542
+2.2%
0.04%
-31.0%
Q2 2021$25,436,000
-53.2%
293,075
-55.6%
0.06%
-58.9%
Q1 2021$54,383,000
+85.5%
659,583
+104.6%
0.14%
+67.9%
Q4 2020$29,311,000
+98.8%
322,342
-12.6%
0.08%
+61.5%
Q3 2020$14,746,000
+98.1%
368,924
+70.0%
0.05%
+40.5%
Q2 2020$7,444,000
+1337.1%
216,963
+719.3%
0.04%
+1750.0%
Q4 2019$518,000
-51.8%
26,482
-61.7%
0.00%
-50.0%
Q3 2019$1,075,000
-65.5%
69,221
-61.0%
0.00%
-60.0%
Q1 2019$3,117,000
-25.9%
177,404
-45.9%
0.01%
-37.5%
Q4 2018$4,207,000
-44.1%
327,875
-29.1%
0.02%
-23.8%
Q3 2018$7,532,000
+284.3%
462,369
+167.5%
0.02%
+250.0%
Q2 2018$1,960,000
+121.5%
172,845
+90.6%
0.01%
+100.0%
Q1 2018$885,000
-15.1%
90,704
-46.8%
0.00%0.0%
Q4 2017$1,043,000
+848.2%
170,636
+179.1%
0.00%
+200.0%
Q1 2016$110,000
+64.2%
61,141
+206.5%
0.00%
Q4 2015$67,000
+1.5%
19,946
+62.2%
0.00%
Q3 2015$66,00012,3000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$34,0959.92%
Redmile Group, LLC 12,957,222$130,738,3705.35%
GCM Grosvenor Holdings, LLC 1,037,256$10,465,9132.67%
Casdin Capital, LLC 2,050,000$20,684,5001.60%
DAFNA Capital Management LLC 550,940$5,558,9851.57%
Artal Group S.A. 2,600,000$26,2341.46%
Monaco Asset Management SAM 250,000$2,522,5000.76%
Parametrica Management Ltd 32,254$325,4430.67%
Boxer Capital, LLC 1,250,000$12,612,5000.66%
Bellevue Group AG 4,861,279$49,050,3050.65%
View complete list of FATE THERAPEUTICS INC shareholders